Department of Laboratory Medicine, School of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-ku, Seoul, 137-701, South Korea.
Diagn Microbiol Infect Dis. 2011 Sep;71(1):87-9. doi: 10.1016/j.diagmicrobio.2010.12.012. Epub 2011 Mar 11.
Among the extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli, 3.9% of K. pneumoniae showed nonsusceptibility to imipenem or meropenem; and their mechanism was the combination of ESBL and/or plasmid-mediated AmpC β-lactamase production and porin loss. The presence of bla(CTX-M-14) and loss of OmpK36 were associated with higher carbapenem MICs.
在产超广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌和大肠埃希菌中,3.9%的肺炎克雷伯菌对亚胺培南或美罗培南表现出耐药性;其机制是 ESBL 和/或质粒介导的 AmpC β-内酰胺酶产生以及孔蛋白缺失的组合。bla(CTX-M-14)的存在和 OmpK36 的缺失与更高的碳青霉烯类 MIC 相关。